Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-23T06:40:50.806Z Has data issue: false hasContentIssue false

An individualised treatment algorithm for tumour stage 1 glottic squamous cell carcinoma

Published online by Cambridge University Press:  17 October 2013

U Aydil*
Affiliation:
Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey
M Akmansu
Affiliation:
Department of Radiation Oncology, Gazi University School of Medicine, Ankara, Turkey
Y Kizil
Affiliation:
Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey
Ö Yazici
Affiliation:
Department of Radiation Oncology, Gazi University School of Medicine, Ankara, Turkey
S Üstün
Affiliation:
Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey
F Karaloğlu
Affiliation:
Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey
A Köybaşioğlu
Affiliation:
Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey
*
Address for correspondence: Dr Utku Aydil, Gazi Ün Tıp Fak KBB AD, 06500 Beşevler, Ankara, Turkey Fax: +90 312 202 4357 E-mail: utkuaydil@yahoo.com

Abstract

Objective:

To report and discuss the outcome of a treatment algorithm for patients with tumour stage 1 glottic squamous cell carcinoma.

Method:

A retrospective outcome analysis study was performed using data from a tertiary referral centre.

Results:

Sixty-nine patients were treated with radiotherapy and 26 with surgery, in accordance with the treatment algorithm. Five-year overall survival rates were the same for both treatment groups (92 per cent). Five-year disease-specific survival rates were 100 per cent for surgery, 98 per cent for radiotherapy and 99 per cent overall. The overall 5-year laryngeal preservation rate was 89.1 per cent, being 95.7 per cent for surgery patients and 86.7 per cent for radiotherapy patients (p = 0.502). There was no significant association between laryngeal preservation rates and age (p = 0.779), anterior commissure involvement (p = 0.081), tumour stage (1a or 1b) (p = 0.266) or treatment modality (surgery or radiotherapy; p = 0.220). There was no significant difference in local recurrence rates between the two treatment groups (19.3 per cent for radiotherapy vs 10.0 per cent for surgery; p = 0.220). The overall 5-year regional recurrence rate was 1.2 per cent.

Conclusion:

Tumour stage 1 glottic carcinoma can be managed with different treatment modalities, following an individualised treatment algorithm, with results comparable to published outcomes.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Spector, JG, Sessions, DG, Chao, KSC, Haughey, BH, Hanson, JM, Simpson, JR et al. Stage I (T1N0M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice presentation. Head Neck 1999;21:707–173.0.CO;2-2>CrossRefGoogle Scholar
2Nomiya, T, Nemoto, K, Wada, H, Takai, Y, Yamada, S. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 2008;118:1417–21CrossRefGoogle ScholarPubMed
3Sjögren, EV, van Rossum, MA, Langeveld, TP, Voerman, MS, van de Kamp, VA, Friebel, MO. Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg 2008;134:965–72CrossRefGoogle ScholarPubMed
4Cellai, E, Frata, P, Magrini, SM, Paiar, F, Barca, R, Fondelli, S et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 2005;63:1378–86CrossRefGoogle Scholar
5Steiner, W, Ambrosch, P, Rödel, RMW, Kron, M. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 2004;114:1485–91CrossRefGoogle ScholarPubMed
6Franchin, G, Minatel, E, Gobitti, C, Talamini, R, Vaccher, E, Sartor, G et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer 2003;98:765–72CrossRefGoogle Scholar
7Karatzanis, AD, Psychogios, G, Zenk, J, Waldfahrer, F, Hornung, J, Velegrakis, GA et al. Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope 2009;119:1704–8CrossRefGoogle ScholarPubMed
8Peeters, AJ, van Gogh, CD, Goor, KM, Verdonck de Leeuw, IM, Langendijk, JA, Mahieu, HF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2004;261:534–40CrossRefGoogle ScholarPubMed
9Anonymous. Larynx. In: Edge, SB, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A, eds. AJCC Cancer Staging Manual, 7th edn.New York: Springer, 2010;5767Google ScholarPubMed
10Kasapoglu, F, Erisen, L, Coskun, H, Basut, O. Endolaryngeal cordectomy using cold instruments for treatment of T1 glottic cancers. Eur Arch Otorhinolaryngol 2007;264:1065–70CrossRefGoogle ScholarPubMed
11Goor, KM, Peeters, AJ, Mahieu, HF, Langendijk, JA, Leemans, CR, Verdonck-de Leeuw, IM et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007;29:128–36CrossRefGoogle ScholarPubMed
12Schrijvers, ML, van Riel, EL, Langendijk, JA, Dikkers, FG, Schuuring, E, van der Wal, JE et al. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma. Head Neck 2009;31:759–64CrossRefGoogle ScholarPubMed
13Chone, CT, Yonehara, E, Martins, JEF, Altemani, A, Crespo, AN. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 2007;133:882–7CrossRefGoogle ScholarPubMed
14Sachse, F, Stoll, W, Rudack, C. Evaluation of treatment results with regard to initial anterior commissure involvement in early glottic carcinoma treated by external partial surgery or transoral laser microresection. Head Neck 2009;31:531–7CrossRefGoogle ScholarPubMed
15Rödel, RM, Steiner, W, Müller, RM, Kron, M, Matthias, C. Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 2009;31:583–92CrossRefGoogle ScholarPubMed
16Anonymous. General information on cancer staging and end-results reporting (part I). In: Edge, SB, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A, eds. AJCC Cancer Staging Manual, 7th edn.New York: Springer, 2010;314Google ScholarPubMed
17Connor, S. Laryngeal cancer: how does the radiologist help? Cancer Imaging 2007;7:93103CrossRefGoogle ScholarPubMed
18Gowda, RV, Henk, JM, Mais, KL, Sykes, AJ, Swindell, R, Slevin, NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol 2003;68:105–11CrossRefGoogle ScholarPubMed
19Holsinger, FC, Funk, E, Roberts, DB, Diaz, EM Jr.Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck 2006;28:779–84CrossRefGoogle ScholarPubMed
20Ganly, I, Patel, SG, Matsuo, J, Singh, B, Kraus, DH, Boyle, JO et al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 2006;132:5966CrossRefGoogle ScholarPubMed
21McLaughlin, MP, Parsons, JT, Fein, DA, Stringer, SP, Cassisi, NJ, Mendenhall, WM et al. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck 1996;18:229–353.0.CO;2-1>CrossRefGoogle ScholarPubMed
22Sjögren, EV, Langeveld, TPM, Baatenburg de Jong, RJ. Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option. Head Neck 2008;30:1167–74CrossRefGoogle ScholarPubMed